Hyperbaric Oxygen Therapy for Post-Surgical Healing
Hyperbaric oxygen therapy (HBOT) represents a valuable adjunctive treatment modality for enhancing post-surgical healing outcomes. By delivering 100% oxygen at pressure (typically 2.0-2.5 ATA), HBOT significantly increases dissolved oxygen in plasma, enhancing oxygen delivery to compromised tissues and promoting optimal wound healing environments.
Many of our surgeon partners refer patients to us both pre- and post-surgically. They refer patients pre-surgically to help improve pre-surgical tissue condition, reduce the risk of infection and improve healing outcomes. They refer patients post-surgically to accelerate the healing process and address incisions that present challenges in healing, including on radiation-damaged tissue.
Key Clinical Benefits: HBOT addresses the fundamental pathophysiology of impaired wound healing by correcting tissue hypoxia, stimulating angiogenesis, enhancing fibroblast proliferation, and optimizing immune function. This multi-modal approach can significantly improve surgical outcomes while reducing complications.
HBOT essentially gives the body's natural healing processes a significant boost when normal recovery isn't progressing as expected or when complications arise that threaten the surgical outcome.
Hyperbaric oxygen therapy (HBOT) represents a valuable adjunctive treatment modality for enhancing post-surgical healing outcomes. By delivering 100% oxygen at pressure (typically 2.0-2.5 ATA), HBOT significantly increases dissolved oxygen in plasma, enhancing oxygen delivery to compromised tissues and promoting optimal wound healing environments.
Many of our surgeon partners refer patients to us both pre- and post-surgically. They refer patients pre-surgically to help improve pre-surgical tissue condition, reduce the risk of infection and improve healing outcomes. They refer patients post-surgically to accelerate the healing process and address incisions that present challenges in healing, including on radiation-damaged tissue.
Key Clinical Benefits: HBOT addresses the fundamental pathophysiology of impaired wound healing by correcting tissue hypoxia, stimulating angiogenesis, enhancing fibroblast proliferation, and optimizing immune function. This multi-modal approach can significantly improve surgical outcomes while reducing complications.
HBOT essentially gives the body's natural healing processes a significant boost when normal recovery isn't progressing as expected or when complications arise that threaten the surgical outcome.
Enhanced Oxygen Delivery
Angiogenesis Stimulation
Collagen Synthesis
Antimicrobial Effects
Anti-Inflammatory Response
Stem Cell Mobilization
Randomized Controlled Trials
Multiple RCTs demonstrate significant improvement in wound healing rates, reduced infection rates, and decreased time to complete healing when HBOT is used as adjunctive therapy.
Meta-Analysis Data
Systematic reviews show consistent benefits across various surgical specialties, with particular efficacy in high-risk patient populations.
Clinical Outcomes:
• 65% reduction in healing time
• 40% decrease in infection rates
• 50% reduction in reoperation rates
• 30% improved cosmetic outcomes
Compromised Surgical Sites: Wounds with poor vascular supply, tension, or signs of delayed healing; prevention of wound dehiscence
High-Risk Patients: Diabetic patients, immunocompromised individuals (HIV, autoimmune diseases like SLE/MS, transplant patients), elderly patients
Complex Reconstructive Surgery: Flap procedures, tissue grafts, extensive soft tissue reconstruction
Radiation-Damaged Tissue: Surgery in previously irradiated fields with compromised healing potential
Orthopedic Procedures: Complex fractures, nonunions, osteomyelitis treatment
Cardiac Surgery: Heart surgery, CABG procedures, valve replacements
Urological Surgery: Prostate surgery, complex urological reconstructions
Gastrointestinal Surgery: Anastomotic healing, particularly in high-risk colorectal procedures
Optimal Candidates
• High-risk surgical patients
• Diabetic patients undergoing surgery
• Patients with peripheral vascular disease
• Immunocompromised individuals (HIV, SLE, MS, transplant patients)
• Previous radiation therapy patients
• Complex reconstructive procedures
• Smokers (with cessation counseling)
• Age >65 with multiple comorbidities
Relative Contraindications
• Untreated pneumothorax
• Severe COPD with CO2 retention
• Uncontrolled seizure disorder
• Claustrophobia (relative)
• Current chemotherapy (consult oncology)
• Pregnancy (limited data)
• Concurrent bleomycin therapy
Pre-operative: 2 to 5 sessions generally. For high-risk patients or those with compromised tissue perfusion, from 5 to 10 sessions. For patients with osteomyelitis, the recommendation is 20 sessions prior to surgery.
Post-operative: Initiate within 24-48 hours when medically stable. Earlier initiation generally correlates with better outcomes.
Combined approach: Pre-conditioning followed by post-operative treatment shows superior results in complex cases.
Integration with Standard Care: HBOT serves as an adjunct to, not replacement for, standard wound care practices. Optimal outcomes are achieved when combined with appropriate surgical technique, infection control, nutritional optimization, and comprehensive wound management protocols.
While HBOT represents an additional treatment cost, studies demonstrate significant cost savings through reduced hospital stays, fewer complications, decreased reoperation rates, and faster return to work. The cost-effectiveness is particularly pronounced in high-risk patient populations.
• Diabetic lower extremity wounds
• Compromised skin grafts/flaps
• Chronic refractory osteomyelitis
• Osteoradionecrosis
• Necrotizing soft tissue infections
Bay Area Hyperbarics works closely with referring physicians to ensure seamless patient care coordination. Our medical team provides regular progress reports and maintains open communication throughout the treatment course.
Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials
Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials
Studies have suggested that hyperbaric oxygen therapy (HBOT) is effective in the healing of diabetic foot ulcer (DFU); however, there is a lack of consensus. Therefore, to assess the efficacy of HBOT on diabetic foot ulcer among diabetic patients, controlled clinical trials were searched through PubMed, EMBASE, Clinical key, Ovid Discovery, ERMED, Clinical Trials.gov databases for randomized controlled trials (RCTs) and other sources until 15 September 2020.
Application of wound healing management algorithms in hyperbaric oxygen therapy improve clinical outcomes and, at the same time, markedly reduce expenditures.
Oxygen plays key nutritional and “cell signal” roles across the many phases of wound healing: hypoxia is a common etiology in wounds that fail to respond to standard management within anticipated time lines, and hyperbaric doses of oxygen are known to increase hypoxic wound oxygen tensions to normal, even supraphysiologic levels. If HBO therapy is to be effective, therefore, prospective demonstration of hypoxia is critical.
Have more Questions?